DYLAMPIK
Live / Applied — First extension granted (statement of use) (as of 27 Feb 2026)
What this means for you
Not registered yet, but its 18 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98909481
- Mark type
- Stylized text
- Filed
- 18 Dec 2024
- Published for opposition
- 08 Jul 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating muscle diseases or disorders; pharmaceutical preparations for treating cardiac diseases or disorders; pharmaceutical preparations for treating metabolic diseases or disorders; pharmaceutical preparations for treating central nervous system diseases or disorders
Owner
- Dyne Therapeutics, Inc., Waltham, MA, US
- Dyne Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 28 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2026 — SOU EXTENSION 1 GRANTED
- 27 Feb 2026 — SOU EXTENSION 1 FILED
- 27 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jun 2025 — ASSIGNED TO EXAMINER
- 18 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Dec 2024 — NEW APPLICATION ENTERED